Clinical and Cost Impact of Complete and Incomplete Rotavirus Vaccination
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2014
At a glance
- Drugs RIX 4414 (Primary) ; Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 28 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Jul 2013 Planned End Date changed from 1 Feb 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 19 Sep 2012 Planned number of patients (1) added.